Commit To Purchase Intra-Cellular Therapies At $7.50, Earn 9.3% Using Options –

This article was originally published on this site

Investors eyeing a purchase of Intra-Cellular Therapies Inc ( ITCI) shares, but cautious about paying the going market price of $16.16/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents. Collecting that bid as the premium represents a 9.3% return against the $7.50 commitment, or a 7.4% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Top YieldBoost Puts of Stocks with Recent Secondaries »

Selling a put does not give an investor access to ITCI’s upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $7.50 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Intra-Cellular Therapies Inc sees its shares decline 53.5% and the contract is exercised (resulting in a cost basis of $6.80 per share before broker commissions, subtracting the 70 cents from $7.50), the only upside to the put seller is from collecting that premium for the 7.4% annualized rate of return. Below is a chart showing the trailing twelve month trading history for Intra-Cellular Therapies Inc, and highlighting in green where the $7.50 strike is located relative to that history: The chart above, and the stock’s historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the January 2019 put at the $7.50 strike for the 7.4% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Intra-Cellular Therapies Inc (considering the last 253 trading day closing values as well as today’s price of $16.16) to be 71%. For other put options contract ideas at the various different available expirations, visit the ITCI Stock Options page of